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Summary: An economical enzymatic assay for HDL phosphatidyl choline is described, äs adapted for the
Cobas-Bio analyser (Hoffmann LaRoche). This method entails the enzymatic cleavage of phosphatidyl cho-
line by phospholipase C from B.cereus, hydrolysis of phosphoryl choline and enzymatic determination of
choline with choline oxidase by an enzymatic colour test. This method provides consistent values and is, by
comparison to the enzymatic UV method (assaying choline with choline kinase in an optical test procedure),
simpler to perform, more precise, and less expensive.
Eine rationelle Methode zur Bestimmung von HDL-Phosphatidylcholin
Zusammenfassung: Es wird eine rationelle enzymatische Bestimmungsmethode von HDL-Phosphatidylcho-
lin beschrieben, die an den Analysator Cobas-Bio (Hoffmann LaRoche) adaptiert wurde. Das Prinzip dieser
Methode besteht in der enzymatischen Spaltung von Phosphatidylcholin mittels Phospholipase C aus B.cereus
und der enzymatischen Bestimmung von Cholin mittels Cholinoxidase in einem enzymatischen Farbtest nach
Hydrolyse von Phosphorylcholin. Das Verfahren liefert im Vergleich zur enzymatischen UV-Methode (Mes-
sung* von Cholin mittels Cholinkinase im optischen Test) übereinstimmende Werte und ist im Vergleich zur
enzymatischen UV-Methode einfacher durchführbar, präziser und billiger.
Introduction
It has been shown in epidemiological (1—5) and clin-
ical (6, 7) studies that HDL cholesterpl represents a
risk indicator for cpronary heart disease. HDL, how-
ever, do not constitute a single substance, but com-
prise a heterogeiieous mixture of macromölecules of
various composition, metabolism, and physicochem-
ieal properties. Only after the additional determina-
tion of other HDL components, such äs HDL apoli-
poproteins or HDL phospholipids, is it possible to
gain any Information regarding HDL composition or
HDL mass.
This group recently reported pn an enzymatic meth-
od for determining HDL phosphatidyl choline (8).
The principle of the method involves the specific
cleavage Pf phosphatidyl choline by phospholipase C
from B.cereus, followed by enzymatic determination
of choline hydrolysed from phosphorylcholine by
choline kinase, äs detected by an optical method. Al-
though the newly proposed enzymatic method is less
laborious and more precise than the previously em-
ployed conventional chemical method, it involves
various disadvantages including relatively high cost
of analysis, relatively low processing rate (20—30
samples/day in duplicate) and poor automation
eapability.
In the following we report a modification of the en-
zymatic HDL phosphatidyl choline assay, which we
have adapted for use with the Cobas-Bio centrifugal
analyser (Hoffmann LaRoche).
Materials and Methode
Phosphotungstic acid/MgCh precipitation reagent
Boehringer Mannheim, Order No. 400971.
Phospholipase C from B.cereus (EC 3.1.4.3)
Boehringer Mannheim, Order No. 241709
(phospholipase C diluted to 90 kU/1 with 3.2 mmol/1 ammonium
sulphate solution).
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Alkaline phosphatase (EC 3.1.3.1), specific activity 140 U/mg
Boehringcr Mannheim, Order No. 108162.
Choline oxidasc from Arthrobacter globiformis (EC 1.1.3.17),
specific activity 10 U/mg protein
Boehringer Mannheim, Order No. 430323.
Monotest cholesterol 'High Performance', CHOD-PAP method
Boehringcr Mannheim, Order No. 237574.
Sample mater ia l
We used samples of the serum collected for the 'Prospective




HDL was isolated by ultracentrifugation or by precipitation of
apolipoprotein B-containing lipoproteins with phosphotungstic
acid/MgCh, s described in detail elsewhere (9).
Enzymattc determination of HDL phosphatidyl choline
Choline kinase method: This method is described in detail else-
where (8).
Choline oxidase method: The assay of phosphatidyl choline by the
choline oxidase method was performed on the Cobas^Bio centri-
fugal analyser (Hoffmann LaRoche) according to the following
sequence:
Phosphatidyl choline phosphoHpase S phosphorylchqline
.4- diglycerides
Phosphorylcholine alkalinc phosphataH choline -l· phosphate
Choline + 02 choline oxidase> betaine + H2O2
The reagent Solutions were freshly prepared in the following man-
ner:
reaction solution A - 10 ml monotest cholesterol
- 500 μΐ phosphoHpase C (90 kU/1)
- 50 μΐ alkaline phosphatase (1400 kU/1)
Start reagent B - 100 μΐ choline oxidase (50 kU/1)
- 500 μΐ NaOsolution (0.15 moi/1)
• r
3 μΐ sample were mixed with 300 ul solution A and incubated at
37 °C for 15 minutes. The absorbance of this mixture at 500 nm
was recorded. Exactly 7.0 minutes after addition of 10 μΐ of the
Start reagent B, absorbance at 500 nm was recorded againj keep-
ing the temperature at 37 °C. Calculation was made ori.the basis of
the difference in absorbance ΔΑ with respect to a choline Stan-
dard. The cohcentration of the choline Standard was determined
gravimetrically and by means of the choline kinase method (8).
The parameter list for the Cobas Bio was s follows:
1 Units
2 Calculation factor
3 Standard l conc
. 4 Standard 2 conc
5 Standard 3 conc
6 Limit
7 Temperature (Deg. C)
8 Type of analysis
9 Wavelength (nm)
10 Sample volume (μΐ)
11 Diluent volume (μΐ)
12 Reagent volume (μΐ)
13 Incubation time (sec.)
14 Start reagent volume (μΐ)
15 Time of first reading (sec.)
16 Time interval (sec.)
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Fig. 1. Measured phosphatidyl choline values s a function of the
amount of sample used. Special control serum for HDL
cholesterol (Boehringef Mannheim, Lot. No. 1-201) was
dissolved with one-fourth the given volume of water (1:1)




The choline oxidase activity in the test solution was
chosen so that the i dieatoi reaction (formation of 4-
(p-benzoquinonemonoamino)-phen 2one) did not
run to eornpletion within the ineubation period. Un^
der the given conditions the increase in extinetion
time was constant over the measurement period,
which was selected at 7.0 minutes.
Linearity
In order to determine the linearity, a solution of
lyophilised control serum was made with one-fourth
the original w ter Content, a dilution series was
made, and phosphatidyl choline Content was deter-
mined in the samples prepared. The measured values
were proportional to the sample dilution within the
r nge tested (0.17 mmol/1-2.73 mmol/1) (fig. 1).
J, Clin. Chem. Clin. Biochem. / Vol. 21* 1983 / No. 10
Schriewer, Jung, Emke and Assmann: Economical assay for HDL phosphatidyl choline 613
Accuracy
Comparison of the HDL phosphatidyl choline values
obtained with the choline oxidase and choline kinase
methods showed good correspondence of results
(r = 0.9779, y = 0.9396x + 0.0577, n = 32).
Regression analysis of the data of the apolipoprotein
B-free superiiatant s well s of the d > 1.063 kg/l
fraction isolated by ultracentrifugation also indicated
that the phosphatidyl choline values obtained with
the choline oxidase method from the apolipoprotein
B-free supernatant corresponded weil with the phos-
phatidyl choline values for HDL fractions isolated by
ultracentrifugation (r = 0.97, y = 0.89x -h 0.12, n =
90) (fig. 2).
Precision
Precision of the series was represented by a coef-
ficient of Variation of 2.8% (x = 0.993 mniol/1, n =
10). Day-to-day precision was determined with se^
rum samples taken from a fresh serum pool and
stored in aliquots at -20 °C. The coefficient of Varia-
tion for day-to-day precision was 5.49% (x = 1.012
mrnol/1, n = 19).
Discussion
Routine assay of phospholipids without undue effort
has been possible since the advent of commercially
available phospholipases with specific cleavage
properties. The phosphatidyl choline assay recently
described by us (8) entails the specific cleavage of
phosphatidyl choline into diglycerides and phos-
phorylcholine by phospholipase C, hydrolytic cleav-
age of phpsphorylcholine with alkaline phosphatase,
followed by enzymatic determination of choline with
choline kinase, using an optical test (UV method).
Substantial drawbacks to the UV method are, how-
ever, the high cost of analysis^ relatively low process-
ing rate (approx. 20—30 samples/day in duplicate),
and difficulties associated with automation of the
method.
The improved method described here is distin-
guished from the UV method by the change in indi-
cator reaction, in which choline is converted by cho-
line oxidase in an enzymatic colour test. In Order to
conserve choline oxidase, the reaction may be re-
corded with fixed-time kinetics. Prerequisites are









0.1 0.3 0.5 1.0 15
Phosphatidyl choline
(uliracentrifugation, d> 1.063 kg/l) [mmol/D
2.0
Fig. 2. Regression analysis of HDL phosphatidyl choline values
obtained from the d > 1.063 kg/l HDL fraction isolated by
ultracentrifugation (x) and from the supernatant following
phosphotungstic acid/MgCh precipitation (y). r = 0.97,
y = O>89x 4- 0.12, n = 90.
and complete cleavage of phosphatidyl choline dur-
ing the pre-incubation period, which we established
by thin-layer chromatography of the lipid extract
subsequent to phospholipase C and alkaline phos-
phatase action. We used an aquepus choline Stan-
dard s a reference. We believe the use of micellar
phosphatidyl choline is problematic, since phospha-
tidyl choline is then present in a physicochemical
form completely different from that in native serum,
the apolipoprotein B-free supernatant, or the HDL
fraction isolated by ultracentrifugation.
The assay of phosphatidyl choline in the apolipopro-
tein B-free supernatant (HDL phosphatidyl choline)
was adapted by us for use with the Cobas-Bio cen-
trifugal analyser. This is a simplification which pro-
vides for a significant improvement in precision of
the method and a reduction in reagent costs. Use of
the commercial cholesterol monotest renders super-
fluous the preparation of reagents for the choline as-
say, but further reduction in reagent costs may be
achieved by mixing one's own reagents. The phos-
phatidyl choline assay started by choline oxidase is
not influenced by the reagent for cholesterol deter-
mination, since the colour reaction for all of the cho-
lesterol is complete by the end of the preincubation
period. The data obtained with the enzymatic colour
test on the Cobas-Bio analyser correlates well with
the HDL phosphatidyl choline values obtained man-
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ually with the UV method. In view of the close cor-
relation of the values from the UV method with
those obtained by the conventional chemical method
(8), the present study does not include a comparison
between data from the enzymatic colour test and the
chemical method. The results of this study also indi-
cate a close correlation of phosphatidyl choline
values between the apolipoprotein B-free super-
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